VIPIND.NS - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 30/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.1x).

Beta (Market Relation)

0.09x

Defensive

Volatility (5Y p.a.)

37.0% p.a.

5-Year Horizon

Max Drawdown (5Y)

-65.2%

5-Year Horizon

Sharpe Ratio

-0.41

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	-34.7%
3 Years	37.9%	-62.3%	-0.75	-25.8%
5 Years	37.0%	-65.2%	-0.41	-12.6%
10 Years	40.4%	-68.1%	0.1	+6.5%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 336%.

Unprofitable business model: The company is currently generating net losses.

🔴 High valuation risk: Avg P/E of 95.1 (Elevated multiple compression risk)

Strong cyclicality: The business model is sensitive to economic downturns.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.0% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -68.1% in the extended horizon.